Crizotinib capsules belong to which generation of targeted therapy drugs?

Crizotinib capsules belong to the first generation of targeted therapy drugs. Crizotinib capsule is the world's first targeted drug approved for the treatment of ALK-positive non-small cell lung cancer. It belongs to the first generation of targeted drugs for the treatment of lung cancer. It blocks the growth and proliferation of tumor cells by inhibiting the activity of specific tyrosine kinase receptors (such as ALK, ROS1, and Met).

Crizotinib capsules are mainly used to treat patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC), and patients with ROS1-positive advanced non-small cell lung cancer.

Drug characteristics and efficacy

Crizotinib capsules, as a targeted therapy drug, are highly specific and can accurately act on tumor cells carrying ALK or ROS1 gene mutations, while having less impact on normal cells. Clinical studies have shown that crizotinib capsules can significantly reduce the risk of recurrence and metastasis of patients, prolong their survival, and improve their quality of life.

Crizotinib capsules should be used under the guidance of a doctor, and the recommended dose is 250 mg twice dailyeach time until the disease progresses or the patient cannot tolerate it. Dosage adjustments may be necessary in patients with severe renal impairment. During the period of taking crizotinib capsules, the patient's liver function, electrolytes and other indicators should be regularly monitored, and possible side effects should be observed, such as visual impairment, digestive system reactions, etc.

For pregnant women, lactating women, the elderly, and patients with a history of specific diseases, crizotinib capsules should be used with caution under the guidance of a doctor. Crizotinib capsules were developed by Pfizer and were approved for marketing by the U.S. Food and Drug Administration (FDA) in August 2011. As the world's firstALKTargeted drug, crizotinib capsule plays an important role in the field of lung cancer treatment and has been widely used in clinical practice.